Joel Greenblatt's ANIP Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 24,095 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $1.85 M, representing 0.01% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in ANIP, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2015, adding 34,594 shares. Largest reduction occurred in Q2 2015, reducing 25,621 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's ANI Pharmaceuticals (ANIP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ANI Pharmaceuticals (ANIP) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -8,747 | Reduce 26.63% | 24,095 | $76.90 |
| Q4 2025 | +24,254 | Add 282.42% | 32,842 | $78.94 |
| Q3 2025 | +8,588 | New Buy | 8,588 | $91.60 |
| Q3 2024 | -4,929 | Sold Out | 0 | $0.00 |
| Q2 2024 | -2,821 | Reduce 36.40% | 4,929 | $63.68 |
| Q1 2024 | -1,519 | Reduce 16.39% | 7,750 | $69.13 |
| Q4 2023 | +4,165 | Add 81.60% | 9,269 | $55.14 |
| Q3 2023 | +5,104 | New Buy | 5,104 | $58.06 |
| Q4 2018 | -14,451 | Sold Out | 0 | $0.00 |
| Q3 2018 | -1,511 | Reduce 9.47% | 14,451 | $56.54 |
| Q2 2018 | +15,962 | New Buy | 15,962 | $66.78 |
| Q1 2017 | -4,137 | Sold Out | 0 | $0.00 |
| Q4 2016 | -626 | Reduce 13.14% | 4,137 | $60.67 |
| Q3 2016 | -2,561 | Reduce 34.97% | 4,763 | $66.34 |
| Q2 2016 | -4,364 | Reduce 37.34% | 7,324 | $55.84 |
| Q1 2016 | +11,688 | New Buy | 11,688 | $33.62 |
| Q4 2015 | -24,801 | Sold Out | 0 | $0.00 |
| Q3 2015 | +11,743 | Add 89.93% | 24,801 | $39.51 |
| Q2 2015 | -25,621 | Reduce 66.24% | 13,058 | $62.03 |
| Q1 2015 | +34,594 | Add 846.85% | 38,679 | $62.54 |
| Q4 2014 | +4,085 | New Buy | 4,085 | $56.30 |
Joel Greenblatt's ANI Pharmaceuticals Investment FAQs
Joel Greenblatt first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q4 2014, acquiring 4,085 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held ANI Pharmaceuticals, Inc. (ANIP) for 21 quarters since Q4 2014.
Joel Greenblatt's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q1 2015, adding 38,679 shares worth $2.42 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 24,095 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $1.85 M.
As of the Q1 2026 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 38,679 shares, as reported at the end of Q1 2015.